PARIS, Oct 14 (Reuters) - (This Oct. 14 story has been refiled to remove a picture) The French government needs guarantees from drugmaker Sanofi (SASY.PA), opens new tab that production of its popular ...

Acetaminophen or Paracetamol (Doliprane (60ml)) helps to reduce fever and to relieve a headache with mild to moderate pain. It is also used with other pain medications to treat low back pain, ...

According to Sanofi, the sale of a controlling 50 percent stake in Opella to Clayton Dubilier & Rice (CD&R) has valued the maker of France's leading painkiller, Doliprane, at €16 billion. "Sanofi and ...

Politicians from across the political spectrum are up in arms over healthcare giant Sanofi's plans to sell France's best-known medical drug Doliprane to US investors, a move critics say would lead to ...

Doliprane, whose active ingredient is acetaminophen, is the most popular medication in France. (Ptyx/Wikimedia Commons via Courthouse News) MARSEILLE, France (CN) — The French pharmaceutical company ...

Unions in France are planning a walkout over the planned sale of the pharmaceutical company that makes popular painkiller brand Doliprane to a US investment fund Employees at French pharmaceutical ...

French pharmaceutical company Sanofi confirmed on Monday its plans to sell a controlling stake in its consumer health unit Opella to a US investment fund, after providing the French government with ...

Souveraineté sanitaire et industrielle, perte d'emplois, rentabilité à court terme... Les polémiques sont nombreuses depuis l'annonce de Sanofi de sa séparation avec sa filiale "grand public" Opella ...

French pharmaceutical company Sanofi's plan to sell 50% of Opella, which produces France's favorite drug, to an American investment fund exposes the gap between political promises of ...

PARIS (Reuters) - The French government needs guarantees from drugmaker Sanofi that production of its popular Doliprane painkiller will stay in France to allow the sale of its consumer health branch ...